Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CTKBCytek Biosciences, Inc.

Nasdaq · CIK 0001831915
Filer categoryAccelerated filer
Entity typeoperating
SIC3826 Laboratory Analytical Instruments
FY end1231
XBRL facts346

Identity from submissions API

NameCytek Biosciences, Inc.
CIK0001831915
TickersCTKB
ExchangesNasdaq
Entity typeoperating
CategoryAccelerated filer
SIC3826 Laboratory Analytical Instruments
EIN472547526
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone(877) 922-9835
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
CA
Mailing address
47215 LAKEVIEW BOULEVARD
FREMONT
CA
94538
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

472 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 xslF345X06/form4-11202026_091129.xml 0001181190-26-000008 7662
2026-11-20 4 xslF345X06/form4-11202026_091131.xml 0001515140-26-000006 7706
2026-11-20 4 xslF345X06/form4-11202026_091110.xml 0001874041-26-000010 26295
2026-11-20 4 xslF345X06/form4-11202026_091147.xml 0001337252-26-000006 7693
2026-11-20 4 xslF345X06/form4-11202026_091126.xml 0001878824-26-000005 20745
2026-11-20 4 xslF345X06/form4-11202026_091103.xml 0001872873-26-000007 26292
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001386060-26-000063 005-92754 261550287 34 7666
2026-11-12 4 xslF345X06/form4-11132026_011110.xml 0002141966-26-000004 6277
2026-11-04 10-Q 10-Q 0001628280-26-070259 001-40632 261523581 34 10234488 1 1
2026-11-04 8-K 8-K 2.02,9.01 0001193125-26-447300 001-40632 261522449 34 280269 1 1
2026-11-03 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-122222 005-92754 261519331 34 19469
2026-09-29 8-K 8-K 5.03,9.01 0001193125-26-407330 001-40632 261423708 34 347010 1 1
2026-09-02 144 xsl144X01/primary_doc.xml 0001950047-26-008998 001-40632 261354911 33 4723
2026-08-24 8-K 8-K 7.01,8.01,9.01 0001193125-26-361705 001-40632 261306261 34 158533 1 1
2026-08-20 4 xslF345X06/form4-08202026_080812.xml 0001872873-26-000006 26304
2026-08-20 4 xslF345X06/form4-08202026_080854.xml 0001878824-26-000004 20740
2026-08-20 4 xslF345X06/form4-08202026_080825.xml 0001181190-26-000007 7659
2026-08-20 4 xslF345X06/form4-08202026_080828.xml 0001515140-26-000005 7703
2026-08-20 4 xslF345X06/form4-08202026_080801.xml 0001337252-26-000005 7690
2026-08-20 4 xslF345X06/form4-08202026_080851.xml 0001874041-26-000009 26291
2026-08-12 4 xslF345X06/form4-08122026_100817.xml 0002141966-26-000002 8711
2026-08-06 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-092212 005-92754 261250938 34 18242
2026-08-05 10-Q 10-Q 0001628280-26-053496 001-40632 261244673 34 9868569 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-335212 001-40632 261243944 34 280464 1 1
2026-08-04 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001386060-26-000050 005-92754 261240214 34 7545
2026-07-15 8-K 8-K 5.02 0001193125-26-304789 001-40632 261177553 34 137726 1 1
2026-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-001934 005-92754 261161249 34 11012
2026-06-30 3 xslF345X06/form3-07012026_010722.xml 0002141966-26-000001 10264
2026-06-25 8-K 8-K 5.02 0001193125-26-282871 001-40632 261122385 34 133235 1 1
2026-06-16 4 xslF345X06/form4-06162026_080659.xml 0001874041-26-000007 4821
2026-06-16 8-K 8-K 5.07 0001193125-26-272582 001-40632 261094643 34 144329 1 1
2026-06-12 4 xslF345X06/form4-06122026_110614.xml 0001873083-26-000001 7247
2026-06-12 4 xslF345X06/form4-06122026_110625.xml 0001181190-26-000005 8454
2026-06-12 3 xslF345X06/form3-06122026_110630.xml 0001181190-26-000004 9410
2026-06-12 4 xslF345X06/form4-06122026_110652.xml 0001337252-26-000003 8201
2026-06-12 4 xslF345X06/form4-06122026_110652.xml 0001902959-26-000001 11906
2026-06-12 4 xslF345X06/form4-06122026_110651.xml 0001221786-26-000001 11906
2026-06-12 4 xslF345X06/form4-06122026_110655.xml 0001515140-26-000003 11906
2026-06-02 8-K 8-K 5.02 0001193125-26-253538 001-40632 261056236 34 132298 1 1
2026-06-01 SD SD 0001193125-26-251413 001-40632 261050776 34 23131
2026-05-20 4 xslF345X06/form4-05202026_100527.xml 0001515140-26-000002 7686
2026-05-20 4 xslF345X06/form4-05202026_090523.xml 0001337252-26-000002 7673
2026-05-20 4 xslF345X06/form4-05202026_090518.xml 0001874041-26-000005 26347
2026-05-20 4 xslF345X06/form4-05202026_090503.xml 0001991396-26-000002 26363
2026-05-20 4 xslF345X06/form4-05202026_090527.xml 0001872873-26-000004 26445
2026-05-20 4 xslF345X06/form4-05202026_090502.xml 0001878824-26-000002 20781
2026-05-20 4 xslF345X06/form4-05202026_090558.xml 0001873091-26-000004 26332
2026-05-18 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-063322 005-92754 26995340 34 18075
2026-05-07 10-Q 10-Q 0001628280-26-032293 001-40632 26954726 34 8713771 1 1
2026-05-07 8-K 8-K 2.02,9.01 0001193125-26-211948 001-40632 26953467 34 248723 1 1
2026-04-28 ARS ARS 0001140361-26-017481 001-40632 26908553 34 1686857
2026-04-28 DEFA14A DEFA14A 0001140361-26-017480 001-40632 26908540 34 3812723
2026-04-28 DEF 14A DEF 14A 0001140361-26-017479 001-40632 26908515 34 7147394 1 1
2026-04-09 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-041573 005-92754 26852558 34 15510
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001029 005-92754 26799704 34 7213
2026-03-13 4 xslF345X05/form4-03132026_100343.xml 0001874041-26-000004 4684
2026-03-12 4 xslF345X05/form4-03122026_080314.xml 0001337252-26-000001 7535
2026-03-12 4 xslF345X05/form4-03122026_080318.xml 0001873091-26-000003 25575
2026-03-12 4 xslF345X05/form4-03122026_080302.xml 0001991396-26-000001 25600
2026-03-12 4 xslF345X05/form4-03122026_080314.xml 0001872873-26-000003 25592
2026-03-12 4 xslF345X05/form4-03122026_080323.xml 0001878824-26-000001 20013
2026-03-12 4 xslF345X05/form4-03122026_080319.xml 0001874041-26-000003 25580
2026-03-12 4 xslF345X05/form4-03122026_080344.xml 0001515140-26-000001 7549
2026-02-27 S-8 S-8 0001193125-26-082841 333-293867 26700589 33 193648 1 1
2026-02-26 10-K 10-K 0001628280-26-012352 001-40632 26689578 34 13182076 1 1
2026-02-26 8-K 8-K 2.02,9.01 0001193125-26-076768 001-40632 26688438 34 303931 1 1
2026-02-20 4 xslF345X05/form4-02202026_100254.xml 0001872873-26-000002 9063
2026-02-20 4 xslF345X05/form4-02202026_100256.xml 0001874041-26-000002 9061
2026-02-20 4 xslF345X05/form4-02202026_100232.xml 0001873091-26-000002 9051
2026-01-13 8-K 8-K 2.02,9.01 0001193125-26-011748 001-40632 26530218 34 156718 1 1
2025-11-20 4 xslF345X05/form4-11212025_121157.xml 0001874041-25-000002 26001
2025-11-20 4 xslF345X05/form4-11212025_121133.xml 0001991396-25-000002 20585
2025-11-20 4 xslF345X05/form4-11212025_121102.xml 0001873091-25-000002 25989
2025-11-20 4 xslF345X05/form4-11212025_121127.xml 0001878824-25-000002 14995
2025-11-20 4 xslF345X05/form4-11202025_111154.xml 0001872873-25-000002 26015
2025-11-20 4 xslF345X05/form4-11202025_111124.xml 0001515140-25-000002 7550
2025-11-20 4 xslF345X05/form4-11202025_111125.xml 0001337252-25-000004 7536
2025-11-17 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-25-284205 005-92754 251490061 34 193992
2025-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-25-020758 005-92754 251471538 34 7546
2025-11-05 10-Q 10-Q 0001628280-25-049697 001-40632 251455161 34 10470620 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-266973 001-40632 251454202 34 274095 1 1
2025-08-20 4 xslF345X05/form4-08202025_090828.xml 0001415889-25-022524 25999
2025-08-20 4 xslF345X05/form4-08202025_090849.xml 0001415889-25-022523 20585
2025-08-20 4 xslF345X05/form4-08202025_090831.xml 0001415889-25-022522 25980
2025-08-20 4 xslF345X05/form4-08202025_090803.xml 0001415889-25-022521 26013
2025-08-20 4 xslF345X05/form4-08202025_090817.xml 0001415889-25-022520 14993
2025-08-20 4 xslF345X05/form4-08202025_090800.xml 0001415889-25-022518 7545
2025-08-20 4 xslF345X05/form4-08202025_090818.xml 0001415889-25-022516 7535
2025-08-06 10-Q 10-Q 0001628280-25-038422 001-40632 251190688 34 10134562 1 1
2025-08-06 8-K 8-K 2.02,9.01 0001193125-25-174459 001-40632 251189689 34 273161 1 1
2025-07-29 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000774 005-92754 251159047 34 6253
2025-07-18 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-003345 005-92754 251134032 34 11235
2025-06-24 8-K 8-K 5.07 0001193125-25-145725 001-40632 251068999 34 141085 1 1
2025-06-20 4 xslF345X05/form4-06202025_080655.xml 0001415889-25-017868 8347
2025-06-20 3 xslF345X02/form3-06202025_080615.xml 0001415889-25-017861 9826
2025-06-20 4 xslF345X05/form4-06202025_080610.xml 0001415889-25-017853 8078
2025-06-20 4 xslF345X05/form4-06202025_080611.xml 0001415889-25-017844 8070
2025-06-20 4 xslF345X05/form4-06202025_080658.xml 0001415889-25-017840 8078
2025-06-20 4 xslF345X05/form4-06202025_080640.xml 0001415889-25-017838 8078
2025-06-09 4 xslF345X05/form4-06092025_090626.xml 0001415889-25-016319 7064
2025-06-09 4 xslF345X05/form4-06092025_090627.xml 0001415889-25-016316 6929
2025-06-09 4 xslF345X05/form4-06092025_090659.xml 0001415889-25-016312 7055
2025-06-09 4 xslF345X05/form4-06092025_080607.xml 0001415889-25-016306 7064
2025-06-03 4 xslF345X05/form4-06032025_090608.xml 0001415889-25-015442 5193
2025-05-30 SD SD 0001193125-25-132091 001-40632 251010665 34 22565
2025-05-21 4 xslF345X05/form4-05212025_090504.xml 0001415889-25-013984 14993
2025-05-21 4 xslF345X05/form4-05212025_090536.xml 0001415889-25-013982 26012
2025-05-21 4 xslF345X05/form4-05212025_090505.xml 0001415889-25-013980 25973
2025-05-21 4 xslF345X05/form4-05212025_090534.xml 0001415889-25-013978 20585
2025-05-21 4 xslF345X05/form4-05212025_090505.xml 0001415889-25-013976 26001
2025-05-21 4 xslF345X05/form4-05212025_090559.xml 0001415889-25-013974 7548
2025-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001398344-25-009599 005-92754 25951336 34 7476
2025-05-08 10-Q 10-Q 0001628280-25-023927 001-40632 25927466 34 9582343 1 1
2025-05-08 8-K 8-K 2.02,9.01 0001193125-25-115965 001-40632 25926204 34 258500 1 1
2025-04-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-000481 005-92754 25891954 34 6252
2025-04-28 ARS ARS 0001140361-25-016037 001-40632 25880690 34 1798113
2025-04-28 DEFA14A DEFA14A 0001140361-25-016036 001-40632 25880672 34 3697521
2025-04-28 DEF 14A DEF 14A 0001140361-25-016032 001-40632 25880639 34 6919136 1 1
2025-03-12 4 xslF345X05/form4-03122025_090346.xml 0001415889-25-007891 14901
2025-03-12 4 xslF345X05/form4-03122025_090353.xml 0001415889-25-007890 14943
2025-03-12 4 xslF345X05/form4-03122025_090352.xml 0001415889-25-007889 14922
2025-03-12 4 xslF345X05/form4-03122025_090329.xml 0001415889-25-007888 14917
2025-03-12 4 xslF345X05/form4-03122025_090354.xml 0001415889-25-007887 7555
2025-03-06 4 xslF345X05/form4-03062025_100342.xml 0001415889-25-007283 8408
2025-03-06 4 xslF345X05/form4-03062025_100326.xml 0001415889-25-007282 8419
2025-03-06 4 xslF345X05/form4-03062025_100358.xml 0001415889-25-007281 8412
2025-03-06 4 xslF345X05/form4-03062025_100338.xml 0001415889-25-007280 8384
2025-03-06 4 xslF345X05/form4-03062025_100358.xml 0001415889-25-007279 8403
2025-02-28 S-8 S-8 0001193125-25-042608 333-285446 25691325 33 247193 1 1
2025-02-28 10-K 10-K 0001628280-25-008780 001-40632 25681070 34 12306568 1 1
2025-02-27 8-K 8-K 2.02,9.01 0001193125-25-039225 001-40632 25678768 34 306943 1 1
2025-02-20 4 xslF345X05/form4-02202025_110252.xml 0001415889-25-004928 9059
2025-02-20 4 xslF345X05/form4-02202025_110227.xml 0001415889-25-004926 9071
2025-02-20 4 xslF345X05/form4-02202025_110246.xml 0001415889-25-004924 9074
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004271 005-92754 25631683 34 16667
2025-02-05 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-001200 005-92754 25592217 34 11856
2025-01-15 8-K 8-K 2.02,9.01 0001193125-25-006599 001-40632 25531241 34 162852 1 1
2024-11-20 4 xslF345X05/form4-11202024_111129.xml 0001415889-24-027369 14946
2024-11-20 4 xslF345X05/form4-11202024_111121.xml 0001415889-24-027368 20337
2024-11-20 4 xslF345X05/form4-11202024_111121.xml 0001415889-24-027367 20367
2024-11-20 4 xslF345X05/form4-11202024_111152.xml 0001415889-24-027366 20349
2024-11-20 4 xslF345X05/form4-11202024_111112.xml 0001415889-24-027365 20359
2024-11-20 4 xslF345X05/form4-11202024_111103.xml 0001415889-24-027364 7556
2024-11-14 SC 13G CYTEK BIOSCIENCES, INC. 0000902664-24-006628 005-92754 241463414 34 43603
2024-11-14 SC 13G/A fp0090934-11_sc13ga.htm 0001398344-24-020821 005-92754 241460037 34 65144
2024-11-07 10-Q 10-Q 0001628280-24-045834 001-40632 241432401 34 10233738 1 1
2024-11-05 8-K 8-K 2.02,9.01 0001193125-24-251268 001-40632 241427859 34 276515 1 1
2024-09-16 4 xslF345X05/form4-09162024_100916.xml 0001415889-24-023460 4692
2024-09-12 8-K 8-K 5.02 0001193125-24-217558 001-40632 241293814 34 138802 1 1
2024-08-21 4 xslF345X05/form4-08212024_100824.xml 0001415889-24-021864 7556
2024-08-21 4 xslF345X05/form4-08212024_100843.xml 0001415889-24-021860 20540
2024-08-21 4 xslF345X05/form4-08212024_100843.xml 0001415889-24-021858 20365
2024-08-21 4 xslF345X05/form4-08212024_100846.xml 0001415889-24-021857 20358
2024-08-21 4 xslF345X05/form4-08212024_100816.xml 0001415889-24-021856 20363
2024-08-21 4 xslF345X05/form4-08212024_100840.xml 0001415889-24-021855 20347
2024-08-21 4 xslF345X05/form4-08212024_100852.xml 0001415889-24-021854 14942
2024-08-06 10-Q 10-Q 0001628280-24-035264 001-40632 241180513 34 9815369 1 1
2024-08-06 8-K 8-K 2.02,9.01 0001193125-24-194907 001-40632 241179515 34 276210 1 1
2024-06-11 8-K 8-K 5.07 0001193125-24-159094 001-40632 241035716 34 148668 1 1
2024-06-07 4 xslF345X05/form4-06072024_110607.xml 0001415889-24-016083 8358
2024-06-07 3 xslF345X02/form3-06072024_110631.xml 0001415889-24-016082 9598
2024-06-07 4 xslF345X05/form4-06072024_110634.xml 0001415889-24-016081 7712
2024-06-07 4 xslF345X05/form4-06072024_100612.xml 0001415889-24-016078 7721
2024-06-07 4 xslF345X05/form4-06072024_100635.xml 0001415889-24-016077 7721
2024-06-07 4 xslF345X05/form4-06072024_100635.xml 0001415889-24-016076 7586
2024-05-31 SD SD 0001193125-24-151917 001-40632 241010517 34 22199
2024-05-22 4 xslF345X05/form4-05222024_100502.xml 0001415889-24-014149 20554
2024-05-22 4 xslF345X05/form4-05222024_100556.xml 0001415889-24-014148 20358
2024-05-22 4 xslF345X05/form4-05222024_100534.xml 0001415889-24-014147 20360
2024-05-22 4 xslF345X05/form4-05222024_100540.xml 0001415889-24-014146 20362
2024-05-22 4 xslF345X05/form4-05222024_100555.xml 0001415889-24-014145 20336
2024-05-22 4 xslF345X05/form4-05222024_100536.xml 0001415889-24-014144 14980
2024-05-15 4 xslF345X05/form4-05152024_110545.xml 0001415889-24-013281 8516
2024-05-08 10-Q 10-Q 0001628280-24-021723 001-40632 24926828 34 9783819 1 1
2024-05-08 8-K 8-K 2.02,9.01 0001193125-24-134238 001-40632 24926504 34 254663 1 1
2024-04-25 ARS ARS 0001140361-24-022073 001-40632 24876777 34 1963389
2024-04-25 DEFA14A DEFA14A 0001140361-24-022067 001-40632 24876743 34 1223495
2024-04-25 DEF 14A DEF 14A 0001140361-24-022063 001-40632 24876723 34 6106242 1 1
2024-04-23 4 xslF345X05/form4-04232024_100439.xml 0001415889-24-011390 5407
2024-04-11 4 xslF345X05/form4-04112024_100410.xml 0001415889-24-010714 6419
2024-04-09 144 xsl144X01/primary_doc.xml 0001950047-24-003012 001-40632 24832987 33 6821
2024-03-21 4 xslF345X05/form4-03212024_100334.xml 0001415889-24-008881 8796
2024-03-20 3 xslF345X02/form3-03212024_120319.xml 0001415889-24-008799 9627
2024-03-19 4 xslF345X05/form4-03192024_100347.xml 0001415889-24-008641 7413
2024-03-19 8-K 8-K 5.02,9.01 0001193125-24-071467 001-40632 24764725 34 220001 1 1
2024-03-18 144 xsl144X01/primary_doc.xml 0001950047-24-002469 001-40632 24759583 33 6113
2024-03-14 S-8 S-8 0001193125-24-067926 333-277936 24750482 33 86763
2024-03-13 4 xslF345X05/form4-03132024_100322.xml 0001415889-24-007872 9287
2024-03-13 4 xslF345X05/form4-03132024_100335.xml 0001415889-24-007870 9317
2024-03-13 4 xslF345X05/form4-03132024_100332.xml 0001415889-24-007868 9293
2024-03-13 4 xslF345X05/form4-03132024_100343.xml 0001415889-24-007865 9292
2024-03-13 4 xslF345X05/form4-03132024_100341.xml 0001415889-24-007863 9387
2024-03-13 4 xslF345X05/form4-03132024_100333.xml 0001415889-24-007861 9275
2024-03-13 10-K 10-K 0001628280-24-010933 001-40632 24746569 34 14336973 1 1
2024-03-08 4 xslF345X05/form4-03082024_110327.xml 0001415889-24-007440 8369
2024-03-08 4 xslF345X05/form4-03082024_110311.xml 0001415889-24-007439 8409
2024-03-08 4 xslF345X05/form4-03082024_110327.xml 0001415889-24-007438 8376
2024-03-08 4 xslF345X05/form4-03082024_110341.xml 0001415889-24-007437 8373
2024-03-08 4 xslF345X05/form4-03082024_110313.xml 0001415889-24-007436 8345
2024-03-08 4 xslF345X05/form4-03082024_110324.xml 0001415889-24-007435 8364
2024-03-01 NT 10-K NT 10-K 0001193125-24-055924 001-40632 24709585 34 88420
2024-03-01 8-K 8-K 2.02,9.01 0001193125-24-054312 001-40632 24706725 34 378100 1 1
2024-02-27 8-K 8-K 5.02 0001193125-24-046891 001-40632 24681817 34 147696 1 1
2024-02-22 SC 13G SC 13G 0001104659-24-026668 005-92754 24666753 34 73856
2024-02-22 4 xslF345X05/form4-02222024_100239.xml 0001415889-24-004899 9072
2024-02-22 4 xslF345X05/form4-02222024_100248.xml 0001415889-24-004898 9091
2024-02-22 4 xslF345X05/form4-02222024_100212.xml 0001415889-24-004895 9074
2024-02-22 4 xslF345X05/form4-02222024_100233.xml 0001415889-24-004892 9060
2024-02-22 4 xslF345X05/form4-02222024_100242.xml 0001415889-24-004886 9175
2024-02-22 4 xslF345X05/form4-02222024_100207.xml 0001415889-24-004881 9074
2024-02-14 SC 13G/A CYTEK BIOSCIENCES, INC. 0000902664-24-001733 005-92754 24639452 34 63037
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036185 005-92754 24638056 34 44567
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036159 005-92754 24637933 34 46033
2024-02-14 SC 13G fp0086869-1_sc13g.htm 0001398344-24-003121 005-92754 24636649 34 46131
2024-02-13 SC 13G/A SCHEDULE 13G/A 0001104659-24-020725 005-92754 24627988 34 13142
2024-01-23 SC 13G/A us23285d1090_012324.txt 0001086364-24-001700 005-92754 24552767 34 13691
2024-01-09 8-K 8-K 2.02,9.01 0001193125-24-004805 001-40632 24521654 34 159777 1 1
2023-12-27 4 FORM 4 SUBMISSION 0001209191-23-059819 5583
2023-12-21 4 FORM 4 SUBMISSION 0001209191-23-059472 5475
2023-12-19 144 xsl144X01/primary_doc.xml 0001950047-23-006319 001-40632 231497719 33 6243
2023-11-28 8-K 8-K 7.01,9.01 0001193125-23-283662 001-40632 231441878 34 2337360 1 1
2023-11-27 4 FORM 4 SUBMISSION 0001209191-23-056733 5478
2023-11-27 4 FORM 4 SUBMISSION 0001209191-23-056732 4657
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056353 17235
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056351 15025
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056350 15000
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056349 15106
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056348 15009
2023-11-21 4 FORM 4 SUBMISSION 0001209191-23-056347 14965
2023-11-15 144 xsl144X01/primary_doc.xml 0001950047-23-005022 001-40632 231410818 33 6105
2023-11-14 10-Q 10-Q 0001628280-23-038974 001-40632 231407257 34 9648897 1 1
2023-11-13 NT 10-Q NT 10-Q 0001193125-23-275998 001-40632 231398495 34 116744
2023-11-09 8-K 8-K 2.02,9.01 0001193125-23-274005 001-40632 231389854 34 223522 1 1
2023-11-08 4 FORM 4 SUBMISSION 0001209191-23-054731 5375
2023-11-07 8-K 8-K 2.02,9.01 0001193125-23-272504 001-40632 231384735 34 289074 1 1
2023-10-25 4 FORM 4 SUBMISSION 0001209191-23-053595 5478
2023-10-24 144 xsl144X01/primary_doc.xml 0001950047-23-004596 001-40632 231342725 33 6286
2023-10-23 4 FORM 4 SUBMISSION 0001209191-23-053410 5370
2023-10-19 144 xsl144X01/primary_doc.xml 0001950047-23-004576 001-40632 231334769 33 6146
2023-10-11 4 FORM 4 SUBMISSION 0001209191-23-052657 5375
2023-10-05 4 FORM 4 SUBMISSION 0001209191-23-052263 4662
2023-09-26 4 FORM 4 SUBMISSION 0001209191-23-050611 5478
2023-09-20 4 FORM 4 SUBMISSION 0001209191-23-050201 5370
2023-09-19 SC 13D/A SC 13D/A 0001104659-23-101999 005-92754 231264751 34 99688
2023-09-08 4 FORM 4 SUBMISSION 0001209191-23-048847 5375
2023-09-07 144 xsl144X01/primary_doc.xml 0001950047-23-003802 001-40632 231242431 33 6159
2023-08-29 3 FORM 3 SUBMISSION 0001209191-23-047658 10531
2023-08-28 4 FORM 4 SUBMISSION 0001209191-23-047533 5479
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046833 15107
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046832 15007
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046829 9439
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046828 15167
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046827 15199
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046826 15019
2023-08-21 4 FORM 4 SUBMISSION 0001209191-23-046824 17234
2023-08-21 144 xsl144X01/primary_doc.xml 0001950047-23-003299 001-40632 231189359 33 6139
2023-08-14 144 xsl144X01/primary_doc.xml 0001950047-23-003038 001-40632 231170518 33 6815
2023-08-08 4 FORM 4 SUBMISSION 0001209191-23-045099 5375
2023-08-08 10-Q 10-Q 0000950170-23-039899 001-40632 231151989 34 17042302 1 1
2023-08-08 8-K 8-K 2.02,9.01 0001193125-23-206235 001-40632 231151596 34 282142 1 1
2023-07-25 4 FORM 4 SUBMISSION 0001209191-23-043340 5479
2023-07-24 144 xsl144X01/primary_doc.xml 0001950047-23-002487 001-40632 231105064 33 6286
2023-07-20 4 FORM 4 SUBMISSION 0001209191-23-042952 5370
2023-07-07 4 FORM 4 SUBMISSION 0001209191-23-041867 5375
2023-06-27 4 FORM 4 SUBMISSION 0001209191-23-039967 5517
2023-06-21 4 FORM 4 SUBMISSION 0001209191-23-038904 5370
2023-06-20 144 xsl144X01/primary_doc.xml 0001950047-23-001783 001-40632 231025551 33 6139
2023-06-20 8-K 8-K 5.07 0001193125-23-169513 001-40632 231023268 34 152170 1 1
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038082 5247
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038081 5242
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038080 5109
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038078 5239
2023-06-16 4 FORM 4 SUBMISSION 0001209191-23-038076 5233
2023-06-07 4 FORM 4 SUBMISSION 0001209191-23-035222 5375
2023-06-07 144 xsl144X01/primary_doc.xml 0001950047-23-001357 001-40632 23999027 33 6158
2023-05-25 4 FORM 4 SUBMISSION 0001209191-23-032259 5516
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031276 17227
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031266 14955
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031265 9433
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031264 15099
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031262 14997
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031260 15012
2023-05-19 4 FORM 4 SUBMISSION 0001209191-23-031246 14991
2023-05-15 144 xsl144X01/primary_doc.xml 0001950047-23-000614 001-40632 23923075 33 6104
2023-05-15 8-K/A 8-K/A 9.01 0001193125-23-144952 001-40632 23921876 34 496561 1 1
2023-05-10 4 FORM 4 SUBMISSION 0001209191-23-028568 5377
2023-05-09 10-Q 10-Q 0000950170-23-019777 001-40632 23902797 34 15114038 1 1
2023-05-09 8-K 8-K 2.02,9.01 0001193125-23-139445 001-40632 23902471 34 280392 1 1
2023-05-08 144 xsl144X01/primary_doc.xml 0001950047-23-000450 001-40632 23898109 33 6228
2023-05-05 SC 13G/A us23285d1090_050423.txt 0001306550-23-009134 005-92754 23892225 34 13548
2023-04-28 ARS FORM ARS 0001140361-23-021537 001-40632 23866197 34 1644769
2023-04-28 DEFA14A DEFA14A 0001140361-23-021531 001-40632 23866149 34 2261952
2023-04-28 DEF 14A DEF14A 0001140361-23-021528 001-40632 23866077 34 2748065
2023-04-25 4 FORM 4 SUBMISSION 0001209191-23-025617 5519
2023-04-24 144 xsl144X01/primary_doc.xml 0001950047-23-000221 001-40632 23840356 33 6286
2023-04-20 4 FORM 4 SUBMISSION 0001209191-23-025029 5369
2023-04-19 144 xsl144X01/primary_doc.xml 0001950047-23-000176 001-40632 23830223 33 7557
2023-04-11 4 FORM 4 SUBMISSION 0001209191-23-024043 5374
2023-03-24 4 FORM 4 SUBMISSION 0001209191-23-021140 5516
2023-03-24 144 xsl144X01/primary_doc.xml 0001950047-23-000057 001-40632 23760259 33 7001
2023-03-21 4 FORM 4 SUBMISSION 0001209191-23-020402 5369
2023-03-20 144 xsl144X01/primary_doc.xml 0001950047-23-000050 001-40632 23746933 33 7547
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016984 8395
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016981 8442
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016980 8403
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016979 10691
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016978 8503
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016977 8422
2023-03-07 4 FORM 4 SUBMISSION 0001209191-23-016975 8363
2023-03-02 S-8 S-8 0001193125-23-056692 333-270200 23695650 33 78107
2023-03-01 10-K 10-K 0000950170-23-005610 001-40632 23694942 34 22020473 1 1
2023-02-28 4 FORM 4 SUBMISSION 0001209191-23-013889 5487
2023-02-28 8-K 8-K 2.02,9.01 0001193125-23-053897 001-40632 23685646 34 326551 1 1
2023-02-28 8-K 8-K 2.01,9.01 0001193125-23-052702 001-40632 23678987 34 146238 1 1
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012359 11390
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012357 9364
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012356 9157
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012355 9325
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012352 9263
2023-02-23 4 FORM 4 SUBMISSION 0001209191-23-012351 7558
2023-02-14 SC 13G/A CYTEK BIOSCIENCES, INC. 0000902664-23-001808 005-92754 23629201 34 60164
2023-02-13 8-K 8-K 1.01,7.01,9.01 0001193125-23-035865 001-40632 23618783 34 217317 1 1
2023-02-10 4 FORM 4 SUBMISSION 0001209191-23-008517 5338
2023-02-09 SC 13G SCHEDULE 13G 0001104659-23-015749 005-92754 23602901 34 13007
2023-02-08 4 FORM 4 SUBMISSION 0001209191-23-007911 5345
2023-02-07 4 FORM 4 SUBMISSION 0001209191-23-007670 6405
2023-02-03 SC 13G us23285d1090_020323.txt 0001306550-23-007104 005-92754 23584714 34 13391
2023-01-25 4 FORM 4 SUBMISSION 0001209191-23-004922 5486
2023-01-20 4 FORM 4 SUBMISSION 0001209191-23-004327 5339
2023-01-10 4 FORM 4 SUBMISSION 0001209191-23-002859 5344
2022-12-29 4 FORM 4 SUBMISSION 0001209191-22-062882 5444
2022-12-20 4 FORM 4 SUBMISSION 0001209191-22-062236 5340
2022-12-09 4 FORM 4 SUBMISSION 0001209191-22-060573 6872
2022-11-30 4 FORM 4 SUBMISSION 0001209191-22-059113 10653
2022-11-28 4 FORM 4 SUBMISSION 0001209191-22-058890 5447
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058475 9158
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058474 11390
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058472 9122
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058467 9262
2022-11-22 4 FORM 4 SUBMISSION 0001209191-22-058465 9159
2022-11-16 4 FORM 4 SUBMISSION 0001209191-22-057368 9019
2022-11-09 10-Q 10-Q 0000950170-22-023935 001-40632 221373248 34 17169699 1 1
2022-11-09 8-K 8-K 2.02,9.01 0001193125-22-281247 001-40632 221373029 34 301027 1 1
2022-11-08 4 FORM 4 SUBMISSION 0001209191-22-056149 5345
2022-11-02 4 FORM 4 SUBMISSION 0001209191-22-055368 8247
2022-11-02 3 FORM 3 SUBMISSION 0001209191-22-055367 6505
2022-11-01 8-K 8-K 5.02,9.01 0001193125-22-275058 001-40632 221351467 34 208715 1 1
2022-10-25 4 FORM 4 SUBMISSION 0001209191-22-054563 5447
2022-10-20 4 FORM 4 SUBMISSION 0001209191-22-054210 5340
2022-10-11 4 FORM 4 SUBMISSION 0001209191-22-053368 5345
2022-09-28 4 FORM 4 SUBMISSION 0001209191-22-051488 5447
2022-09-20 4 FORM 4 SUBMISSION 0001209191-22-050770 5340
2022-09-09 4 FORM 4 SUBMISSION 0001209191-22-049368 5345
2022-08-26 S-3ASR S-3ASR 0001193125-22-231398 333-267118 221206101 33 1331678
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047576 4951
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046949 11388
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046948 9162
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046947 9156
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046946 9260
2022-08-19 4 FORM 4 SUBMISSION 0001209191-22-046945 9324
2022-08-10 4 FORM 4 SUBMISSION 0001209191-22-045286 5345
2022-08-10 10-Q 10-Q 0000950170-22-016500 001-40632 221152278 34 15214737 1 1
2022-08-10 8-K 8-K 2.02,9.01 0001193125-22-217376 001-40632 221152073 34 301168 1 1
2022-08-03 4 FORM 4 SUBMISSION 0001209191-22-044309 5651
2022-08-03 SC 13G/A formsc13ga.htm 0001493152-22-021197 005-92754 221133761 34 199064
2022-07-20 4 FORM 4 SUBMISSION 0001209191-22-042761 5340
2022-07-08 4 FORM 4 SUBMISSION 0001209191-22-041705 5345
2022-06-22 4 FORM 4 SUBMISSION 0001209191-22-038768 5339
2022-06-09 4 FORM 4 SUBMISSION 0001209191-22-035656 5345
2022-06-06 8-K 8-K 5.07 0001193125-22-168332 001-40632 22998192 34 150681 1 1
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034261 5200
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034259 5206
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034257 5209
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034253 5289
2022-06-03 3 FORM 3 SUBMISSION 0001209191-22-034245 6229
2022-06-03 4 FORM 4 SUBMISSION 0001209191-22-034227 5427
2022-06-03 3 FORM 3 SUBMISSION 0001209191-22-034218 6319
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031172 11382
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031170 9160
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031168 9151
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031164 9255
2022-05-20 4 FORM 4 SUBMISSION 0001209191-22-031161 9116
2022-05-12 4 FORM 4 SUBMISSION 0001209191-22-028461 5341
2022-05-12 10-Q 10-Q 0000950170-22-009425 001-40632 22915301 34 13034459 1 1
2022-05-11 8-K 8-K 2.02,9.01 0001193125-22-147538 001-40632 22914010 34 277071 1 1
2022-04-27 4 FORM 4 SUBMISSION 0001209191-22-025897 8211
2022-04-27 3 FORM 3 SUBMISSION 0001209191-22-025896 6386
2022-04-21 4 FORM 4 SUBMISSION 0001209191-22-025251 5338
2022-04-14 DEFA14A DEFA14A 0001140361-22-014567 001-40632 22827217 34 847286
2022-04-14 DEF 14A FORM DEF 14A 0001140361-22-014564 001-40632 22827193 34 2056840
2022-04-08 4 FORM 4 SUBMISSION 0001209191-22-023887 5344
2022-03-23 4 FORM 4 SUBMISSION 0001209191-22-020814 5339
2022-03-17 S-8 S-8 0001193125-22-078438 333-263661 22749812 33 89801
2022-03-17 10-K 10-K 0000950170-22-004106 001-40632 22749101 34 14426628 1 1
2022-03-16 4 OWNERSHIP DOCUMENT 0001104659-22-034568 15567
2022-03-14 SC 13D/A CYTEK BIOSCIENCES, INC. 0001104659-22-033394 005-92754 22737426 34 83279
2022-03-11 4 OWNERSHIP DOCUMENT 0001104659-22-032990 17699
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017217 10797
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017212 11148
2022-03-08 4 FORM 4 SUBMISSION 0001209191-22-017206 7075

Latest XBRL company facts

One latest value per concept from companyfacts (346 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 130.78M 2026-10-31 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
dei EntityPublicFloat Entity Public Float USD 393.00M 2025-06-30 2025 FY 10-K 2026-02-26 0001628280-26-012352
ecd CoSelectedMeasureAmt CoSelectedMeasureAmt USD 201.49M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 1.40M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 1.78M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 113.99 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 3.64M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.12M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 26.92 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
srt StockRepurchaseProgramAuthorizedAmount1 StockRepurchaseProgramAuthorizedAmount1 USD 50.00M 2024-12-11 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 27.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 4.89M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 59.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 13.25M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccruedIncomeTaxesCurrent Accrued Income Taxes, Current USD 2.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 27.15M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 8.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 15.37M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 2.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 457.44M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 4.85M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 15.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 1.18M 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-032293
us-gaap AllowanceForDoubtfulAccountsReceivableRecoveries Accounts Receivable, Allowance for Credit Loss, Recovery USD 0 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-28 0001628280-25-008780
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-032293
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 1.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 1.60M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap Assets Assets USD 446.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AssetsCurrent Assets, Current USD 378.94M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 233.97M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 0 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 365,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 189.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 189.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 1.50M 2023-03-31 2023 Q1 10-Q 2023-05-09 0000950170-23-019777
us-gaap BusinessAcquisitionsProFormaIncomeLossFromContinuingOperationsBeforeChangesInAccountingAndExtraordinaryItemsNetOfTax Business Acquisition, Pro Forma Income (Loss) from Continuing Operations, Net of Tax USD -13.95M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap BusinessAcquisitionsProFormaNetIncomeLoss Business Acquisition, Pro Forma Net Income (Loss) USD -10.81M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap BusinessAcquisitionsProFormaRevenue Business Acquisition, Pro Forma Revenue USD 197.96M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 1.50M 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 44,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap Cash Cash USD 21.93M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 66.81M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 67.19M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -23.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent ChangeInReportingEntityIncomeLossAfterTaxAttributableToParent USD 26,000 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap CommercialPaperAtCarryingValue Commercial Paper, at Carrying Value USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 5.77M 2021-06-30 2021 Q2 10-Q 2021-09-03 0000950170-21-001668
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 1.00B 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 130.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 130.77M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CommonStockValue Common Stock, Value, Issued USD 131,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -36.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest USD 236,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-28 0001628280-25-008780
us-gaap ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -236,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 50.82M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 30.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 18.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 47.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 64.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD -553,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 3.56M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 3.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 129,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 99,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 28.14M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -183,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 3.44M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016500
us-gaap DeferredRevenue Deferred Revenue USD 29.64M 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039899
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 30.28M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 18.74M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap DeferredRevenueRevenueRecognized1 Deferred Revenue, Revenue Recognized USD 19.10M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039899
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD 5.42M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 41.82M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 9.28M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.39M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 33.37M 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 3.25M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 6.38M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 1.47M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 3.11M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 4.91M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Legal Settlements USD 1.84M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Other USD 1.62M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 38.56M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 182,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 4.95M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 1.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap Depreciation Depreciation USD 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 5.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.09 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.09 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.033 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.981 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationDeductions Effective Income Tax Rate Reconciliation, Deduction, Percent pure 0.392 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure 0.052 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0.1 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 4.39M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure -0.147 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.129 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.106 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings Effective Income Tax Rate Reconciliation, Repatriation of Foreign Earnings, Percent pure -0.02 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure -0.444 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.215 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure -0.015 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent pure -0.042 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0.015 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 3.90M 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016500
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 12.30M 2025-09-30 2025 Q3 10-Q 2025-11-05 0001628280-25-049697
us-gaap EquityMethodInvestments Equity Method Investments USD 0 2026-06-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap EquitySecuritiesFvNiGainLoss Equity Securities, FV-NI, Gain (Loss) USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap FinancialInstrumentsOwnedDerivativesAndOtherContractualAgreementsAtFairValue Financial Instruments, Owned, Derivatives and Other Contractual Agreements, at Fair Value USD 115.50M 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045834
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap FinancingReceivableAllowanceForCreditLossesWriteOffs Financing Receivable, Allowance for Credit Loss, Writeoff USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 14.57M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 28.60M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 14.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap FutureMinimumSubleaseRentalsSaleLeasebackTransactions Future Minimum Sublease Rentals, Sale Leaseback Transactions USD 600,000 2021-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -234,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -1.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 53.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap Goodwill Goodwill USD 16.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap GrossProfit Gross Profit USD 80.80M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeLossAttributableToParent Income (Loss) Attributable to Parent, before Tax USD -35.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -44.49M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -29.84M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 14.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -3.03M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 24,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReceivable Income Taxes Receivable USD 1.37M 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004256
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 29.29M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -6.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 3.16M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -78,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 6.41M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD -562,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 448,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -1.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD -1.54M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 4.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 50.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 2.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 4.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 1.02M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -4.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 14.03M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InterestExpense Interest Expense USD 441,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-08 0001628280-24-021723
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 803,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InterestPortionOfMinimumLeasePaymentsSaleLeasebackTransactions Interest Portion of Minimum Lease Payments, Sale Leaseback Transactions USD 1.30M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 12.95M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InventoryGross Inventory, Gross USD 52.37M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InventoryNet Inventory, Net USD 52.37M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 23.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 16.29M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InventoryWriteDown Inventory Write-down USD 831,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 2.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 2.10M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap LeaseCost Lease, Cost USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 20.07M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.13M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.24M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.40M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.64M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.80M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 990,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 3.84M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LessorOperatingLeasePaymentsToBeReceived Lessor, Operating Lease, Payments to be Received USD 16.48M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedAfterRollingYearFive Lessor, Operating Lease, Payments to be Received, after Rolling Year Five USD 4.57M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedNextRollingTwelveMonths Lessor, Operating Lease, Payments to be Received, Next Rolling Twelve Months USD 2.25M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedRollingYearFive Lessor, Operating Lease, Payments to be Received, Rolling Year Five USD 2.22M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedRollingYearFour Lessor, Operating Lease, Payments to be Received, Rolling Year Four USD 2.21M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedRollingYearThree Lessor, Operating Lease, Payments to be Received, Rolling Year Three USD 2.42M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap LessorOperatingLeasePaymentsToBeReceivedRollingYearTwo Lessor, Operating Lease, Payments to be Received, Rolling Year Two USD 2.80M 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap Liabilities Liabilities USD 124.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 446.14M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LiabilitiesCurrent Liabilities, Current USD 84.95M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LitigationReserveNoncurrent Estimated Litigation Liability, Noncurrent USD 5.88M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LitigationSettlementInterest Litigation Settlement Interest USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap LongTermConstructionLoanCurrent Long-term Construction Loan, Current USD 8.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap MarketableSecurities Marketable Securities USD 189.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -509,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap MarketingAndAdvertisingExpense Marketing and Advertising Expense USD 3.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap MinimumLeasePaymentsSaleLeasebackTransactions Minimum Lease Payments, Sale Leaseback Transactions USD 17.04M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsThereafter Minimum Lease Payments, Sale Leaseback Transactions, Thereafter USD 4.71M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinFiveYears Minimum Lease Payments, Sale Leaseback Transactions, within Five Years USD 2.58M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinFourYears Minimum Lease Payments, Sale Leaseback Transactions, within Four Years USD 2.60M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinOneYear Minimum Lease Payments, Sale Leaseback Transactions, Next Twelve Months USD 805,000 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinThreeYears Minimum Lease Payments, Sale Leaseback Transactions, within Three Years USD 2.99M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MinimumLeasePaymentsSaleLeasebackTransactionsWithinTwoYears Minimum Lease Payments, Sale Leaseback Transactions, within Two Years USD 3.35M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 40.90M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 2.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -21.86M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -5.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -37.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetIncomeLossAttributableToNoncontrollingInterest Net Income (Loss) Attributable to Noncontrolling Interest USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -37.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -37.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsNonredeemable Noncontrolling Interest in Net Income (Loss) Other Noncontrolling Interests, Nonredeemable USD -92,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap NoncurrentAssets Long-Lived Assets USD 20.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 2.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingExpenses Operating Expenses USD 119.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -38.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseCost Operating Lease, Cost USD 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 16.23M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 3.46M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 12.78M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 10.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 2.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OperatingLeasesRentExpenseSubleaseRentals1 Operating Leases, Rent Expense, Sublease Rentals USD 600,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.047 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 1.30M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherAssetsCurrent Other Assets, Current USD 2.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 5.55M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 906,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherComprehensiveIncomeLossTaxPortionAttributableToParent1 Other Comprehensive Income (Loss), Tax, Portion Attributable to Parent USD -11.20M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-08 0000950170-23-039899
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 20.21M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 2.33M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD -1.83M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 535,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 2.18M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap OtherReceivables Other Receivables USD 1.59M 2022-03-31 2022 Q1 10-Q 2022-05-12 0000950170-22-009425
us-gaap PaymentsForRepurchaseOfCommonStock Payments for Repurchase of Common Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PaymentsForRepurchaseOfEquity Payments for Repurchase of Equity USD 14.62M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045834
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 0 2022-01-01 2022-06-30 2022 Q2 10-Q 2022-08-10 0000950170-22-016500
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 334,000 2020-01-01 2020-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 103,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 5.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PaymentsToAcquireRealEstateHeldForInvestment Payments to Acquire Real Estate Held-for-investment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001628280-25-008780
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 11.09M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PrepaidInsurance Prepaid Insurance USD 730,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PrepaidRent Prepaid Rent USD 0 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap PrepaidTaxes Prepaid Taxes USD 2.79M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions Present Value of Future Minimum Lease Payments, Sale Leaseback Transactions USD 15.74M 2022-09-30 2022 Q3 10-Q 2022-11-09 0000950170-22-023935
us-gaap ProceedsFromIncomeTaxRefunds Proceeds from Income Tax Refunds USD 180,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap ProceedsFromIssuanceOfDebt Proceeds from Issuance of Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001628280-25-008780
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 6.17M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProceedsFromLoanOriginations1 Proceeds from Loan Originations USD 4.10M 2020-05-07 2022 FY 10-K 2023-03-01 0000950170-23-005610
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 194.59M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 80,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 1.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 851,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProductWarrantyAccrualClassifiedCurrent Product Warranty Accrual, Current USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProductWarrantyExpense Product Warranty Expense USD 961,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -66.54M 2025-01-01 2025-12-31 DEF 14A 2026-04-28 0001140361-26-017479
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 35.98M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 20.61M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 851,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProvisionForLoanLossesExpensed Financing Receivable, Credit Loss, Expense (Reversal) USD 830,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ProvisionForOtherCreditLosses Provision for Other Credit Losses USD 447,000 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-07 0001628280-26-032293
us-gaap PurchaseObligation Purchase Obligation USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 1.45M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 110,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 48,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 376,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap RepaymentsOfDebt Repayments of Debt USD 4.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 28.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap RestrictedCash Restricted Cash USD 0 2026-06-30 2026 Q2 10-Q 2026-08-05 0001628280-26-053496
us-gaap RestrictedCashCurrent Restricted Cash, Current USD 385,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap RestrictedCashEquivalents Restricted Cash Equivalents USD 300,000 2023-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045834
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -138.86M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 145.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap RevenueRemainingPerformanceObligation Revenue, Remaining Performance Obligation, Amount USD 49.02M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap Revenues Revenues USD 142.98M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045834
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 1.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap SalesAndExciseTaxPayableCurrent Sales and Excise Tax Payable, Current USD 3.69M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap SalesAndExciseTaxPayableCurrentAndNoncurrent Sales and Excise Tax Payable USD 100,000 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 36.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap SettlementLiabilitiesCurrent Settlement Liabilities, Current USD 2.43M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 15.05M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value USD/shares 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.901 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004256
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.01 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-12 0000950170-21-004256
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 7.13M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 6.32M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 8.82 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 881,270 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 1.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.69 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 11.05M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.20M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.58 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 74.99M 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 5.62M 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 9.96 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 1.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-17 0000950170-22-004106
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 2.74 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 11.92 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 5.06 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 4.29 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 75,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StandardProductWarrantyAccrual Standard Product Warranty Accrual USD 1.41M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StandardProductWarrantyAccrualWarrantiesIssued Standard Product Warranty Accrual, Increase for Warranties Issued USD 918,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 321.35M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 341.74M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 1.333 2021-07-16 2023 Q3 10-Q 2023-11-14 0001628280-23-038974
us-gaap StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans Stock Issued During Period, Shares, Employee Stock Purchase Plans shares 296,236 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 407,670 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 1.15M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.01M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 644,000 2021-01-01 2021-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD -29,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 13.88M 2023-05-17 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 21.61M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-28 0001628280-25-008780
us-gaap StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 Stock Repurchase Program, Remaining Authorized Repurchase Amount USD 35.00M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap SubleaseIncome Sublease Income USD 57,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001628280-24-045834
us-gaap TemporaryEquityForeignCurrencyTranslationAdjustments Temporary Equity, Foreign Currency Translation Adjustments USD 61,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap TenantImprovements Tenant Improvements USD 575,000 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap TreasuryStockAcquiredAverageCostPerShare Treasury Stock Acquired, Average Cost Per Share USD/shares 5.8 2023-05-17 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 3.53M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions USD 53,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 637,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 513,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 217,000 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 3.10M 2025-12-31 2025 FY 10-K 2026-02-26 0001628280-26-012352
us-gaap USGovernmentAgenciesSecuritiesAtCarryingValue US Government Agencies Securities, at Carrying Value USD 0 2023-12-31 2023 FY 10-K 2024-03-13 0001628280-24-010933
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap VariableInterestEntityOwnershipPercentage Variable Interest Entity, Qualitative or Quantitative Information, Ownership Percentage pure 0.5 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 129.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 129.51M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-04 0001628280-26-070259

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →